Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
People with Alzheimer's disease and significant memory or thinking difficulties:
- People diagnosed with Alzheimer's disease using recognised diagnostic guidelines (IWG 2021), at a stage of major (significant) cognitive impairment
- People aged 40 or older
- People who have a caregiver or support person available
- People who have not formally objected to taking part
People with Alzheimer's disease and mild memory or thinking difficulties:
- People diagnosed with Alzheimer's disease using recognised diagnostic guidelines (IWG 2021), at a stage of minor (mild) cognitive impairment
- People aged 40 or older
- People who have not formally objected to taking part
People with mild or significant cognitive impairment who do NOT have Alzheimer's disease (based on spinal fluid tests showing no Alzheimer's markers):
- People with mild or significant cognitive impairment whose spinal fluid test results show no Alzheimer's disease markers (classified as A- T-)
- People aged 40 or older
- People who have not formally objected to taking part
People with mild cognitive impairment whose spinal fluid test results are mixed or uncertain:
- People with mild cognitive impairment whose spinal fluid results show only some Alzheimer's markers (either A+ T- or A- T+, meaning results do not fully confirm or fully rule out Alzheimer's) (confirm with trial site)
- People aged 40 or older
- People who have not formally objected to taking part
Healthy volunteers:
- People with no concerns or complaints about their memory or thinking
- People who score 26 or above on a standard memory and thinking test (MMSE)
- People who show no signs of cognitive impairment on a standard assessment (CDR score of 0)
- People aged 40 or older
- People who have not formally objected to taking part
Who may not be able to join:
For all participant groups:
- People who are unable to understand the study instructions or to formally indicate whether they object to taking part
- People who are not affiliated with or covered by a social security plan or equivalent scheme (this appears to be a French healthcare system requirement — confirm with trial site)
- People who are legally protected adults or who are under administrative or judicial supervision, as covered under specific French public health law (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mathilde SAUVEE, University Hospital, Grenoble
Phone: 33 (0)4 76 76 57 90
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
to determine the amount of fibrillar and oligomeric amyloid peptide and phosphorylated tau protein measured in the stools of subjects issued as soon as possible after recruitment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.